Health product recall

Teva Canada Limited Product Recall (2020-08-21)

Starting date:
August 21, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-73827

Last updated: 2020-08-28

Summary

  • Product: A. TEVA-CEPHALEXIN 125 B. TEVA-CEPHALEXIN 250

A. TEVA-CEPHALEXIN 125

B. TEVA-CEPHALEXIN 250

Reason

The affected lots may not meet the specification for assay.

Depth of distribution

Wholesalers, Retailers

Affected products

TEVA-CEPHALEXIN 125

DIN, NPN, DIN-HIM

DIN 00342106

Dosage form

Powder for suspension

Strength

Cephalexin (Cephalexin Monohydrate) 125 MG/5ML

Lot or serial number

30309916A
30309917A
30310026A
30310027A

Companies

Recalling Firm
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

TEVA-CEPHALEXIN 250

DIN, NPN, DIN-HIM

DIN 00342092

Dosage form

Powder for suspension

Strength

Cephalexin (Cephalexin Monohydrate) 250 MG/5ML

Lot or serial number

30309837A, 30309838A, 30309839A, 30309840A, 30309841A, 30309842A, 30309843A, 30309844A, 30309972A, 30309973A, 30309974A, 30309975A, 30309976A, 30309977A, 30309978A, 30310049A, 30310050A, 30310051A, 30310052A, 30310053A, 30310123A, 30310124A, 30310125A, 30310126A, 30310150A, 30310151A, 30310152A, 30310153A, 30310154A, 30310218A, 30310219A, 30310220A, 30310221A, 30310278A, 30310279A, 30310280A, 30310281A, 30310383A, 30310384A, 30310385A, 30310386A, 30310434A, 30310435A, 30310436A, 30310437A, 30310438A, 30310494A, 30310496A, 30310497A

Companies

Recalling Firm
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA